1st Quarter - Report
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) for INOVIO PHARMACEUTICALS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$30,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 24, 2018 | $30,000 | Replaced |
| 1st Quarter - Amendment | May 23, 2018 | $30,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| MONA G MOHIB New | Director, Office of Intergovernmental Affairs, Dept. of Labor; Special Assistant, Office Intergovernmental Affairs, White House; Assoc. Director, Office Intergovernmental Affairs, White House |
| ROBERT WASINGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.